LeMaitre (LMAT) possesses solid growth attributes, which could help it handily outperform the market.
LeMaitre (LMAT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CE Curtis Ellergodt Rothschild Investment LLC | 30 | $2,639.8 | $2,995.18 | $355.38 | 13.46% |
| SN Stephanie Nee HARBOR CAPITAL ADVISORS Inc. | 8,998 | $878,082.67 | $898,031.89 | $19,949.22 | 2.27% |
| BG Bart Gancher Intech Investment Management LLC | 7,176 | $601,856.4 | $715,244.12 | $113,387.72 | 18.84% |
| MD Michelle Dubey Yousif Capital Management LLC | 5,666 | $285,220.64 | $565,410.14 | $280,189.5 | 98.24% |
| PF Phillip Fitzsimmons Hennion & Walsh Asset Management Inc. | 14,825 | $1.32M | $1.48M | $163,974.29 | 12.46% |
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | George W. LeMaitre CEO | NASDAQ (NMS) Exchange | 525558201 CUSIP |
| US Country | 655 Employees | 21 May 2026 Last Dividend | - Last Split | 19 Oct 2006 IPO Date |
LeMaitre Vascular, Inc. is a global company focused on the design, manufacture, and marketing of medical devices and implants for vascular surgery. Initially founded as Vascutech, Inc., the company transitioned to its current name in April 2001. With its beginnings in 1983 and headquartered in Burlington, Massachusetts, LeMaitre Vascular stands as a pioneer in the vascular health sector. It offers a diverse range of products, including devices for blood vessel viewing, blood clot removal, and vascular reconstruction, catering to the needs of surgeons and patients worldwide. The company’s approach combines innovative technology with practical applications in vascular surgery, distributing its products through a direct sales force and a network of distributors.